Paul Hastings advises in biotech sale
San Diego-based Ardea Biosciences Inc. tapped Paul Hastings LLP for its sale to United Kingdom-based AstraZeneca PLC for $1.26 billion. Ardea's most promising drug is a treatment for people suffering from gout. The Paul Hastings team included San Diego partner Carl R. Sanchez; Los Angeles partner Alexander M. Lee; and San Diego associates Claudia K. Simon, Kevin C. Reye...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In